ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
2,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
3,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
4,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
4,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
5,1,Scrotal oedema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
6,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,Y
7,1,Biliary obstruction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
8,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
8,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
8,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
9,1,Blood alkaline phosphatase abnormal,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
9,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
12,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
12,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
12,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
12,4,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
12,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
12,6,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
12,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
13,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
13,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
13,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
13,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
14,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
14,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
14,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
14,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
14,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
14,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
15,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
15,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
16,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
17,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
17,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
17,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
18,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
18,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
18,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
19,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
19,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
19,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
21,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
22,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
22,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
22,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
22,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
22,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
23,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
23,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
24,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
25,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
25,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
25,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
25,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
26,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
26,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
27,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
27,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
28,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
29,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
29,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
30,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
30,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
31,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
32,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
32,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
33,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
33,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
33,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
33,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
33,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
34,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
35,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
36,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
37,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
38,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
38,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
38,3,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
38,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
38,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
39,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
40,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
41,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
42,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
42,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
43,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
44,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
45,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
45,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
45,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
45,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
45,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
46,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
46,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
47,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
48,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
48,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
49,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
51,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
51,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
51,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
52,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
53,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
54,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Carcinoembryonic antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
56,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
56,3,Death,Death and sudden death,Fatal outcomes,Genrl,N
56,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
56,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
57,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
58,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
59,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
59,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
60,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
60,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
61,1,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
62,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
63,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
64,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
65,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
66,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
67,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
67,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
67,3,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
67,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
67,5,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
67,6,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
67,7,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
67,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
68,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
68,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,3,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
68,4,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
68,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
68,6,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
69,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
69,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
70,1,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
